Hmmmmmmmmmm, where did this number come from and over what period of time are we talking about?
Projected revenue of XKEM is about $2.5 billion
If 200K patients were on Nicosan tomorrow that's only just over 55 mil a year .... at that pace it would be 45 years in the making to get to 2.5 billion revenue ~ rofl .... so lets say that production ramps up over the next 5 years say 20% each year to say 500K patients .... that's still under 115 mil revenue on that fifth year and a total net profit using a 35% margin (an avg pharmaceutical company is making an avg 30%-35% margin here in the US) with the same 20% growth factor per year of UNDER 150 mil TOTAL for 5 years .... this scenario doesn't include any debt repayment either
Remember, i love the potential here, but 2.5 billion revenue?
Like i said my example was completely generic in nature, just food for thought
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.